Four pharmacists who turned neighborhood drugstores in Michigan and Ohio into a $13 million billing machine just lost their shot at a do-over.
A federal appeals panel last Friday upheld prison sentences for the group, which prosecutors said spent years using five independently operated pharmacies to bill Medicare, Medicaid, and private insurers for prescriptions that were often never actually dispensed. The decision leaves in place multi-year prison terms and a joint restitution tab topping $13 million.
Appeals court affirms convictions
According to the Sixth Circuit opinion, the court affirmed convictions for Raef Hamaed, Kindy Ghussin, Ali Abdelrazzaq, and Tarek Fakhuri on charges of conspiracy to commit health care fraud and wire fraud. The panel found no reversible error and said the trial record backed up what the jury decided.
The opinion, filed last Friday following oral argument earlier this year, keeps intact the sentences the four received earlier this year. According to a Department of Justice release, Hamaed was sentenced to 120 months in prison, Fakhuri to 84 months, Ghussin to 65 months, and Abdelrazzaq to 24 months. Prosecutors said the differing terms reflected each pharmacist’s role across the five pharmacies, and noted the scheme hit Medicare, Medicaid, and Blue Cross Blue Shield of Michigan.
How the alleged billing scheme worked
The Sixth Circuit opinion lays out a straightforward but lucrative scheme. The pharmacists operated Eastside Pharmacy, Harper Drugs, and Wayne Campus Pharmacy in Detroit, along with two Heartland Pharmacy locations in Ohio. Insurers were repeatedly billed for prescriptions that, in many cases, were never picked up by patients.
Instead of reversing those claims when pills sat uncollected on the shelf, staff were instructed to keep the money. According to the opinion, the conspirators kept a stash of labels, forged patient pickup signatures, routinely waived pricey copays to draw in customers, and, at one location, billed for brand-name drugs while handing out generics.
Federal auditors contracted by CMS, including Qlarant, compared wholesaler invoices with pharmacy billing records and documented shortages that produced an estimated loss of more than $13 million, the opinion found.
Defense arguments rejected
Defense lawyers tried to punch holes in both the testimony and the data that underpinned those loss calculations. One attorney even urged the trial judge to strike “every testimony, every figure, everything,” according to the Tampa Free Press.
The appeals panel was not persuaded. It rejected the defendants’ constitutional and procedural objections, concluded the trial was fair, and upheld the loss figures used at sentencing.
Restitution and oversight
The court left in place a joint-and-several restitution order of more than $13 million. The Department of Justice has framed the case as part of a broader federal crackdown on health care billing fraud.
Investigators from the FBI Detroit Field Office and HHS-OIG worked with the Justice Department’s Fraud Section to bring the case, according to the DOJ.
What it means locally
For patients and smaller providers in Michigan and Ohio, the outcome is a reminder that the back-office side of pharmacy work can be just as vulnerable to abuse as the front counter. Gaps around claim reversals and refills that never walked out the door turned into real money in this case, and auditors and pharmacy benefit managers were the ones who eventually caught on.
In practical terms, that likely means tougher audits from insurers and CMS contractors and closer scrutiny of local pharmacies in the near future, as payors look to prevent the next multimillion-dollar “refill” that never leaves the bottle.
